Lido Advisors’s DexCom DXCM Stock Holding History

Lido Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$902K	Buy	+13,400	New	+$893K	﹤0.01%	1142
2026 Q1	–	Sell	-4,000	Closed	-$265K	–	1998
2025 Q4	$265K	Hold	4,000	–	–	﹤0.01%	1629
2025 Q3	$269K	Hold	4,000	–	–	﹤0.01%	1543
2025 Q2	$349K	Hold	4,000	–	–	﹤0.01%	1268
2025 Q1	$273K	Hold	4,000	–	–	﹤0.01%	1250
2024 Q4	$311K	Hold	4,000	–	–	﹤0.01%	1198
2024 Q3	$268K	Buy	+4,000	New	+$328K	﹤0.01%	1206

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lido Advisors's DXCM Position: Q2 2026 in Review

Lido Advisors increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $535K and bringing the position to 41,356 shares worth $2.79M. The position accounts for 0.01% of the portfolio, ranked #685.

Lido Advisors first reported a position in DXCM in Q4 2018 and has held it in 29 quarters since. The position peaked at $8.49M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Lido Advisors held 41,356 shares of DexCom worth $2.79M as of Q2 2026.
Lido Advisors bought 8,032 DexCom shares in Q2 2026, an estimated $535K.
DexCom made up 0.01% of Lido Advisors's portfolio in Q2 2026, its #685 holding.
Lido Advisors first reported a position in DexCom in Q4 2018 and has held it in 29 quarters since.
Lido Advisors's DexCom position peaked at $8.49M in Q1 2024.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.